Stay Updated with the Latest First Trust Capital Strength ETF FTCS News in Real Time
Find FTCS news now at Meyka AI. Stay informed with the latest First Trust Capital Strength ETF stocks updates, including price news, market analysis, and expert insights.
Study: Babies Born Under Sugar Rationing Face Lower Cancer Risk Decades Later
Study of 64,761 UK adults shows those exposed to sugar rationing in infancy had lower cancer risk decades later. Researchers found reductions in liver, prostate, lung, rectal, and breast cancers.
Sui USD Surges 15.9% to $0.8508 as RSI Hits 66.9 on Strong Momentum
Sui USD jumped 15.9% to $0.8508 in 24 hours with volume 2.3x average. RSI at 66.9 and ADX at 29.95 signal strong upward momentum.
Bitcoin Cash Surges 23% to $274.84 as Japan Licensing Fuels Institutional Demand
Bitcoin Cash jumped 23.3% to $274.84 on August 23, 2026, after Japan approved its first new crypto trading license in four years, enabling regulated access for professional investors.
Social Security Benefits Face 22% Cut by 2032 Without Congressional Action
Social Security trust fund projected to deplete by 2032, triggering a 22% automatic benefit cut unless Congress passes reform. Three main proposals being debated.
Fifth Third Backs Payload’s $500M Monthly Payments Platform on August 23
Fifth Third Bank invests in Payload, an embedded payments platform processing $500M monthly. The deal marks Payload’s first outside capital since 2019 and expands payment options across industries.
Lido Staked ETH USD Rallies 5.9% to $2,462 as Momentum Indicators Flash Overbought
STETHUSD jumped 5.9% to $2,462.17 in 24 hours with RSI at 83.88 and price above Bollinger upper band, signaling extreme overbought conditions.
Taylor Sheridan Sued by Writer Over Yellowstone Copyright Claim, August 24
Writer Lauren J. Salkin sues Taylor Sheridan, claiming he stole Yellowstone from her 2016 Sovereign Nation pitch. Lawsuit seeks injunction and damages including profits from the hit series.
Solana Climbs 8.5% to $95.08 as RSI Hits Extreme Overbought 78.7
Solana USD surged 8.5% to $95.08 in 24 hours with RSI at 78.7, signaling overbought conditions and potential pullback risk.
Moderna and Merck’s Melanoma Vaccine Jumps Stocks on Phase 3 Win
Moderna and Merck’s personalized mRNA cancer vaccine succeeded in Phase 3 melanoma trials, reducing disease recurrence. MRNA jumped 8.9% and MRK rose 2.4% on the announcement.